FTRP | tickerfilter.com

Fundamental analysis

74%

Profitability 93%

Dept financing 25%

Liquidity 25%

Performance 80%

Performance

5 Days

-0.93%

1 Month

0.26%

3 Months

-9.78%

6 Months

-47.04%

1 Year

-83.19%

2 Year

-85.61%

Key data

Stock price

$0.84

P/E Ratio

0.00

DAY RANGE

N/A - N/A

EPS

$0.00

52 WEEK RANGE

$0.71 - $6.41

52 WEEK CHANGE

-$0.84

MARKET CAP

49.023 M

YIELD

N/A

SHARES OUTSTANDING

58.215 M

DIVIDEND

N/A

EX-DIVIDEND DATE

N/A

NEXT EARNINGS DATE

N/A

BETA

1.30

PUBLIC FLOAT

AVERAGE 10 VOLUME

$151,137

AVERAGE 30 VOLUME

$159,563

Company detail

CEO:
Region: US
Website: www.fieldtriphealth.com
Employees: 0
IPO year: -

Issue type: Common Stock
Market: XNAS
Industry: Outpatient Mental Health and Substance Abuse Centers
Sector: Health Care and Social Assistance

Field Trip is a global leader in the development and delivery of psychedelic therapies. With its Field Trip Discovery division leading the development of the next generation of psychedelic molecules and conducting advanced research on plant-based psychedelics and its Field Trip Health division building centers for psychedelic therapies opening across North America and Europe along with the digital and technological tools that will enable massive scale, Field Trip help people in need with a simple, evidence-based way to heal and heighten engagement with the world.

FTRP - Field Trip Health Ltd.